Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation.

导出 OA

翻译打印收藏纠错

作者： Carina M,Behr ^[1] ; Hendrik,Koffijberg ^[1] ; Koen,Degeling ^[2] ; Rozemarijn,Vliegenthart ^[3] ; Maarten J,IJzerman ^[4]

作者单位： Health Technology and Services Research, Faculty of Behavioural and Management Science, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. ^[1] Cancer Health Services Research, University of Melbourne Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Melbourne, VIC 3010, Australia. ^[2] Cancer Health Services Research, Centre for Health Policy, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Melbourne, VIC 3010, Australia. ^[3] Dept of Radiology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. ^[4] Health Technology and Services Research, Faculty of Behavioural and Management Science, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. maarten.ijzerman@unimelb.edu.au. ^[5] Cancer Health Services Research, University of Melbourne Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Melbourne, VIC 3010, Australia. maarten.ijzerman@unimelb.edu.au. ^[6] Cancer Health Services Research, Centre for Health Policy, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Melbourne, VIC 3010, Australia. maarten.ijzerman@unimelb.edu.au. ^[7]

关键词 Cardiovascular diseases Cost–benefit analysis Lung neoplasms Mass screening Pulmonary disease, chronic obstructive